|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 1159 |
FusionGeneSummary for AGR2_CSE1L |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: AGR2_CSE1L | Fusion gene ID: 1159 | Hgene | Tgene | Gene symbol | AGR2 | CSE1L | Gene ID | 10551 | 1434 |
| Gene name | anterior gradient 2, protein disulphide isomerase family member | chromosome segregation 1 like | |
| Synonyms | AG-2|AG2|GOB-4|HAG-2|HEL-S-116|HPC8|PDIA17|XAG-2 | CAS|CSE1|XPO2 | |
| Cytomap | 7p21.1 | 20q13.13 | |
| Type of gene | protein-coding | protein-coding | |
| Description | anterior gradient protein 2 homologanterior gradient homolog 2epididymis secretory protein Li 116protein disulfide isomerase family A, member 17secreted cement gland homologsecreted cement gland protein XAG-2 homolog | exportin-2CSE1 chromosome segregation 1-likecellular apoptosis susceptibility proteinchromosome segregation 1-like proteinexp2importin-alpha re-exporter | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | O95994 | P55060 | |
| Ensembl transtripts involved in fusion gene | ENST00000419304, ENST00000419572, ENST00000401412, ENST00000486219, | ENST00000262982, ENST00000542325, ENST00000396192, ENST00000469700, | |
| Fusion gene scores | * DoF score | 4 X 2 X 4=32 | 8 X 9 X 5=360 |
| # samples | 4 | 9 | |
| ** MAII score | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(9/360*10)=-2 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: AGR2 [Title/Abstract] AND CSE1L [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | AGR2 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response | 23220234 |
| Hgene | AGR2 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response | 23220234 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | AA306967 | AGR2 | chr7 | 16832375 | + | CSE1L | chr20 | 47704579 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000419304 | ENST00000262982 | AGR2 | chr7 | 16832375 | + | CSE1L | chr20 | 47704579 | + |
| intron-3CDS | ENST00000419304 | ENST00000542325 | AGR2 | chr7 | 16832375 | + | CSE1L | chr20 | 47704579 | + |
| intron-3CDS | ENST00000419304 | ENST00000396192 | AGR2 | chr7 | 16832375 | + | CSE1L | chr20 | 47704579 | + |
| intron-intron | ENST00000419304 | ENST00000469700 | AGR2 | chr7 | 16832375 | + | CSE1L | chr20 | 47704579 | + |
| intron-3CDS | ENST00000419572 | ENST00000262982 | AGR2 | chr7 | 16832375 | + | CSE1L | chr20 | 47704579 | + |
| intron-3CDS | ENST00000419572 | ENST00000542325 | AGR2 | chr7 | 16832375 | + | CSE1L | chr20 | 47704579 | + |
| intron-3CDS | ENST00000419572 | ENST00000396192 | AGR2 | chr7 | 16832375 | + | CSE1L | chr20 | 47704579 | + |
| intron-intron | ENST00000419572 | ENST00000469700 | AGR2 | chr7 | 16832375 | + | CSE1L | chr20 | 47704579 | + |
| intron-3CDS | ENST00000401412 | ENST00000262982 | AGR2 | chr7 | 16832375 | + | CSE1L | chr20 | 47704579 | + |
| intron-3CDS | ENST00000401412 | ENST00000542325 | AGR2 | chr7 | 16832375 | + | CSE1L | chr20 | 47704579 | + |
| intron-3CDS | ENST00000401412 | ENST00000396192 | AGR2 | chr7 | 16832375 | + | CSE1L | chr20 | 47704579 | + |
| intron-intron | ENST00000401412 | ENST00000469700 | AGR2 | chr7 | 16832375 | + | CSE1L | chr20 | 47704579 | + |
| intron-3CDS | ENST00000486219 | ENST00000262982 | AGR2 | chr7 | 16832375 | + | CSE1L | chr20 | 47704579 | + |
| intron-3CDS | ENST00000486219 | ENST00000542325 | AGR2 | chr7 | 16832375 | + | CSE1L | chr20 | 47704579 | + |
| intron-3CDS | ENST00000486219 | ENST00000396192 | AGR2 | chr7 | 16832375 | + | CSE1L | chr20 | 47704579 | + |
| intron-intron | ENST00000486219 | ENST00000469700 | AGR2 | chr7 | 16832375 | + | CSE1L | chr20 | 47704579 | + |
Top |
FusionProtFeatures for AGR2_CSE1L |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| AGR2 | CSE1L |
| Required for MUC2 post-transcriptional synthesis andsecretion. May play a role in the production of mucus byintestinal cells (By similarity). Proto-oncogene that may play arole in cell migration, cell differentiation and cell growth.Promotes cell adhesion (PubMed:23274113). {ECO:0000250,ECO:0000269|PubMed:18199544, ECO:0000269|PubMed:23274113}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for AGR2_CSE1L |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for AGR2_CSE1L |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for AGR2_CSE1L |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for AGR2_CSE1L |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | AGR2 | C0033578 | Prostatic Neoplasms | 2 | CTD_human |
| Hgene | AGR2 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|